To determine whether policies to limit transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hinder spread of other infectious diseases, we analyzed the National Health Insurance database in Taiwan. Rates of other infections were significantly lower after SARS-CoV-2 prevention measures were announced. This finding can be applied to cost-effectiveness of SARS-CoV-2 prevention.
Keywords: 2019 novel coronavirus disease; COVID-19; SARS-CoV-2; Taiwan; coronavirus disease; enterovirus; influenza; respiratory infections; scarlet fever; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.